Breaking News

Heat Biologics Appoints Head of R&D

By Kristin Brooks | March 5, 2014

Schreiber brings expertise the field of tumor immunology

Taylor H. Schreiber, M.D., Ph.D., has been appointed vice president of R&D at Heat Biologics, Inc. to lead the company's ImPACT Therapy preclinical drug development research team.
 
Dr. Schreiber brings expertise the field of tumor immunology and is co-inventor of significant elements of Heat's ImPACT Technology platform. He has more than 10 years of lab experience and skills in the discovery of therapeutic immuno-oncology compounds. Dr. Schreiber is also a co-inventor of TNFRSF25 agonist technology and has authored numerous tumor immunology and heat shock protein-based cancer immunotherapy abstracts and publications.
 
Jeff Wolf, chief executive officer of Heat, said, "Dr. Schreiber has been intimately involved in the progression of gp96 heat shock protein immunotherapy both as a Ph.D. researcher and as a post-doctoral fellow in the laboratory of Eckhard Podack, M.D., Ph.D., the inventor of Heat's ImPACT Technology platform. Under Taylor's leadership, the Company will seek to generate and evaluate its proprietary ImPACT Therapy for new potential immunotherapeutic oncology product opportunities including the potential for use in combination with checkpoint inhibitors and T-cell costimulatory compounds."
blog comments powered by Disqus
  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • The Role of Alliances in Modern Drug Development

    The Role of Alliances in Modern Drug Development

    Dr. Claire Madden-Smith, Senior Vice President, Juniper Pharma Services||September 8, 2016
    Combining expertise to get drug candidates through development

  • Successful Method Transfer of Solid Oral Dosage

    Successful Method Transfer of Solid Oral Dosage

    John Frankonis, Ropack Pharma Solutions||June 2, 2016
    The three steps outlined will help guide the process of completing a successful analytical method transfer